logo
搜索
菜单

Pharmacody的搜索结果

当前1/2页
排序: 总浏览数
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice 10.3791/51917-v 08:41 min
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia 10.3791/50720-v 10:49 min
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs 10.3791/2460-v
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development 10.3791/56569-v
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay 10.3791/57777-v
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
4.1: Principles of Drug Action 01:24 min
4.1: Principles of Drug Action
Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays 10.3791/59390-v 11:17 min
Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
A Rhodopsin Transport Assay by High-Content Imaging Analysis 10.3791/58703-v 12:11 min
A Rhodopsin Transport Assay by High-Content Imaging Analysis
1.2: Preclinical Development: Overview 01:28 min
1.2: Preclinical Development: Overview
1.3: Clinical Trials: Overview 01:11 min
1.3: Clinical Trials: Overview
3.17: Ligand Binding and Linkage 00:49 min
3.17: Ligand Binding and Linkage
1.9: Pharmacodynamics: Overview and Principles 01:21 min
1.9: Pharmacodynamics: Overview and Principles
2.3: Effects of Chemicals: Overview 01:27 min
2.3: Effects of Chemicals: Overview
3.1: Drug Administration and Therapy Phases: Overview 01:26 min
3.1: Drug Administration and Therapy Phases: Overview
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
7.17: Mechanistic Models: Overview of Compartment Models 01:21 min
7.17: Mechanistic Models: Overview of Compartment Models
4.14: Factors Affecting Protein-Drug Binding: Patient-Related Factors 01:29 min
4.14: Factors Affecting Protein-Drug Binding: Patient-Related Factors
13.3: Drug Dosing: Geriatric Patients 01:15 min
13.3: Drug Dosing: Geriatric Patients
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.8: Pharmacodynamics in Geriatric Patients: Effects of Age 01:27 min
13.8: Pharmacodynamics in Geriatric Patients: Effects of Age
返回顶部